Enzon Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 72   

Articles published

ENZN 1.72 +0.18 (11.69%)
price chart
Enzon Pharmaceuticals Inc Stock Upgraded (ENZN)
Compared to other companies in the Biotechnology industry and the overall market, ENZON PHARMACEUTICALS INC's return on equity significantly exceeds that of both the industry average and the S&P 500.
Enzon Pharmaceuticals Inc (ENZN): Warning! Enzon Pharmaceuticals Is ...
Finance profile for the company! Right off the bat, that doesn't give us a lot of confidence, now does it? Enzon Pharmaceuticals (NASDAQ:ENZN) used to be a research stage biotech firm, focusing on a technology known as PEGylation. PEGylation was used ...
Enzon Pharmaceuticals (ENZN) Is Today's Strong On High Volume Stock
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer. Trade-Ideas LLC identified Enzon Pharmaceuticals ( ENZN) as a strong on ...
Health of Health Care Stocks: Complementary Research on Enzon ...
Moments ago, Analysts Review released new research updates concerning several important developing situations including Enzon Pharmaceuticals, Inc. ENZN, +11.69% Durect Corporation DRRX, -17.90% Vertex Pharmaceuticals Incorporated VRTX, ...
Enzon Pharmaceuticals (ENZN) Stock | Is Now The Time To Buy?
Enzon Pharmaceuticals is a great company which develops treatments for patients who's needs are currently unmet; and investors are interested.
Morning Buzz: Enzon Pharmaceuticals Inc. (ENZN), EMC Corporation (EMC ...  WallStreet Scope
The Window of Opportunity Opens for Enzon Pharmaceuticals (ENZN)
Last Thursday, yours truly pointed out Enzon Pharmaceuticals Inc. (NASDAQ:ENZN) had just sent a message to the trading world that it was in a bullish mood, and mode.
Watch List: Enzon Pharmaceuticals Inc (NASDAQ:ENZN), Akebia Therapeutics ...  Market News Call
Morning Buzz: Baker Hughes Incorporated (BHI), Enzon Pharmaceuticals Inc ...  WallStreet Scope
Enzon Pharmaceuticals Inc (NASDAQ:ENZN) � Wait For A Firm Close Above $1.90
Enzon Pharmaceuticals Inc (NASDAQ:ENZN), a company in the business of licensing drug products, usually would not be on the radar of the investors but a rise of 77% in the current month definitely makes it a name worthy of some attention.
Stocks clocking 52-week highs: Enzon Pharmaceuticals Inc, (NASDAQ:ENZN ...  Wall Street Observer
Special News: Enzon Pharmaceuticals Inc (NASDAQ:ENZN), Gilead Sciences ...  Market News Call
Legendary Investor Icahn Still Slugging Away With Enzon Pharma
Carl C. Icahn has been the principal beneficial shareholder of Icahn Enterprises L.P. (NASDAQ:IEP) and has served as Chairman of the board, a director, and an owner of the company's general partner since 1990. Mr. Icahn heads the investment ...
Related articles »  
Enzon Pharmaceuticals sells Indy drug plant; 100 local jobs safe
Orphan drugs, as they're known in the pharmaceutical industry, treat diseases that afflict fewer than 200,000 patients in the United States.
Related articles »  
Enzon Pharmaceuticals, Inc. (ENZN) Ex-Dividend Date Scheduled for January ...
will begin trading ex-dividend on January 08, 2015. A cash dividend payment of $0.1 per share is scheduled to be paid on January 28, 2015.